These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 39260835

  • 1. Omission of sentinel lymph node biopsy in patients with clinically axillary lymph node-negative early breast cancer (OMSLNB): protocol for a prospective, non-inferiority, single-arm, phase II clinical trial in China.
    Li X, Wang L, Wang Y, Ma L, Zheng R, Ding J, Gong Y, Yao H, Wang J, Zha X.
    BMJ Open; 2024 Sep 10; 14(9):e087700. PubMed ID: 39260835
    [Abstract] [Full Text] [Related]

  • 2. No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial.
    Jung JG, Ahn SH, Lee S, Kim EK, Ryu JM, Park S, Lim W, Jung YS, Chung IY, Jeong J, Chang JH, Shin KH, Chang JM, Moon WK, Han W.
    BMC Cancer; 2022 Feb 20; 22(1):189. PubMed ID: 35184724
    [Abstract] [Full Text] [Related]

  • 3. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á, Péley G, Polgár C, Udvarhelyi N, Rubovszky G, Kovács E, Győrffy B, Kásler M, Mátrai Z.
    Eur J Surg Oncol; 2017 Apr 20; 43(4):672-679. PubMed ID: 28139362
    [Abstract] [Full Text] [Related]

  • 4. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
    Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ.
    Lancet Oncol; 2014 Nov 20; 15(12):1303-10. PubMed ID: 25439688
    [Abstract] [Full Text] [Related]

  • 5. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
    Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P, SOUND Trial Group.
    JAMA Oncol; 2023 Nov 01; 9(11):1557-1564. PubMed ID: 37733364
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A, Musonda P, Mátrai Z, Polgár C, Rényi-Vámos F, Rubovszky G, Kovács E, Sinkovics I, Udvarhelyi N, Török K, Kásler M, Péley G.
    Orv Hetil; 2013 Dec 08; 154(49):1934-42. PubMed ID: 24292111
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
    Fan YJ, Li JC, Zhu DM, Zhu HL, Zhao Y, Zhu XB, Wu G, Bai TT.
    BMC Surg; 2023 Jul 26; 23(1):209. PubMed ID: 37495945
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Axillary treatment for operable primary breast cancer.
    Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW.
    Cochrane Database Syst Rev; 2017 Jan 04; 1(1):CD004561. PubMed ID: 28052186
    [Abstract] [Full Text] [Related]

  • 13. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
    Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P, Baratella P, Chifu C, Sargenti M, Intra M, Gentilini O, Mastropasqua MG, Mazzarol G, Massarut S, Garbay JR, Zgajnar J, Galatius H, Recalcati A, Littlejohn D, Bamert M, Colleoni M, Price KN, Regan MM, Goldhirsch A, Coates AS, Gelber RD, Veronesi U, International Breast Cancer Study Group Trial 23-01 investigators.
    Lancet Oncol; 2013 Apr 04; 14(4):297-305. PubMed ID: 23491275
    [Abstract] [Full Text] [Related]

  • 14. Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolment.
    Tinterri C, Canavese G, Gatzemeier W, Barbieri E, Bottini A, Sagona A, Caraceni G, Testori A, Di Maria Grimaldi S, Dani C, Boni L, Bruzzi P, Fernandes B, Scorsetti M, Zambelli A, Gentile D, SINODAR-ONE Collaborative Group.
    Br J Surg; 2023 Aug 11; 110(9):1143-1152. PubMed ID: 37471574
    [Abstract] [Full Text] [Related]

  • 15. Using the axillary reverse mapping technique to screen breast cancer patients with a high risk of lymphedema.
    Liu S, Wang N, Gao P, Liu P, Yang H, Xie F, Wang S, Liu M, Wang S.
    World J Surg Oncol; 2020 Jun 01; 18(1):118. PubMed ID: 32482174
    [Abstract] [Full Text] [Related]

  • 16. Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis.
    Liu YL, Kuo WL, Lo YF, Tsai HP, Shen SC, Yu CC, Chou HH, Chu CH, Chen SC.
    Biomed J; 2022 Apr 01; 45(2):396-405. PubMed ID: 35562283
    [Abstract] [Full Text] [Related]

  • 17. Omission of axillary sentinel lymph node biopsy in early invasive breast cancer.
    Reimer T.
    Breast; 2023 Feb 01; 67():124-128. PubMed ID: 36658052
    [Abstract] [Full Text] [Related]

  • 18. Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).
    van Roozendaal LM, Vane MLG, van Dalen T, van der Hage JA, Strobbe LJA, Boersma LJ, Linn SC, Lobbes MBI, Poortmans PMP, Tjan-Heijnen VCG, Van de Vijver KKBT, de Vries J, Westenberg AH, Kessels AGH, de Wilt JHW, Smidt ML.
    BMC Cancer; 2017 Jul 01; 17(1):459. PubMed ID: 28668073
    [Abstract] [Full Text] [Related]

  • 19. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.
    Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Maisonneuve P, Gatti G, Mazzarol G, De Cicco C, Manfredi G, Fernández JR.
    Lancet Oncol; 2006 Dec 01; 7(12):983-90. PubMed ID: 17138219
    [Abstract] [Full Text] [Related]

  • 20. Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial.
    Appelgren M, Sackey H, Wengström Y, Johansson K, Ahlgren J, Andersson Y, Bergkvist L, Frisell J, Lundstedt D, Rydén L, Sund M, Alkner S, Vrou Offersen B, Filtenborg Tvedskov T, Christiansen P, de Boniface J, SENOMAC Trialists' Group.
    Breast; 2022 Jun 01; 63():16-23. PubMed ID: 35279508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.